Conformational Sampling Deciphers the Chameleonic Properties of a VHL-Based Degrader

Chameleonicity (the capacity of a molecule to adapt its conformations to the environment) may help to identify orally bioavailable drugs in the beyond-Rule-of-5 chemical space. Computational methods to predict the chameleonic behaviour of degraders have not yet been reported and the identification of molecular chameleons still relies on experimental evidence. Therefore, there is a need to tune predictions with experimental data. Here, we employ PROTAC-1 (a passively cell-permeable degrader), for which NMR and physicochemical data prove the chameleonic behaviour, to benchmark the capacity of two conformational sampling algorithms and selection schemes. To characterize the conformational ensembles in both polar and nonpolar environments, we compute three molecular properties proven to be essential for cell permeability: conformer shape (radius of gyration), polarity (3D PSA), and the number of intramolecular hydrogen bonds. Energetic criteria were also considered. Infographics monitored the simultaneous variation of those properties in computed and NMR conformers. Overall, we provide key points for tuning conformational sampling tools to reproduce PROTAC-1 chameleonicity according to NMR evidence. This study is expected to improve the design of PROTAC drugs and the development of computational sustainable strategies to exploit the potential of new modalities in drug discovery.

[1]  G. Caron,et al.  Refinement of Computational Access to Molecular Physicochemical Properties: From Ro5 to bRo5 , 2022, Journal of medicinal chemistry.

[2]  G. Caron,et al.  Designing Soluble PROTACs: Strategies and Preliminary Guidelines , 2022, Journal of medicinal chemistry.

[3]  D. Langley,et al.  PROTAC targeted protein degraders: the past is prologue , 2022, Nature Reviews Drug Discovery.

[4]  R. Scott Lokey,et al.  Cyclosporin A: Conformational Complexity and Chameleonicity , 2021, J. Chem. Inf. Model..

[5]  G. Tiana,et al.  Managing Experimental 3D Structures in the Beyond‐Rule‐of‐5 Chemical Space: The Case of Rifampicin , 2021, Chemistry.

[6]  G. Caron,et al.  Permeability prediction in the beyond-Rule-of 5 chemical space: focus on cyclic hexapeptides. , 2021, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[7]  Vasanthanathan Poongavanam,et al.  Steering New Drug Discovery Campaigns: Permeability, Solubility, and Physicochemical Properties in the bRo5 Chemical Space. , 2021, ACS medicinal chemistry letters.

[8]  Vasanthanathan Poongavanam,et al.  Solution Conformations Shed Light on PROTAC Cell Permeability , 2020, ACS medicinal chemistry letters.

[9]  Alessandro Pedretti,et al.  The VEGA suite of programs: an versatile platform for cheminformatics and drug design projects , 2020, Bioinform..

[10]  Giulia Caron,et al.  Degraders early developability assessment: face-to-face with molecular properties. , 2020, Drug discovery today.

[11]  M. Shalaeva,et al.  Updating the portfolio of physicochemical descriptors related to permeability in the Beyond the Rule of 5 chemical space. , 2020, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[12]  D. M. Pereira,et al.  Targeted Avenues for Cancer Treatment: The MEK5-ERK5 Signaling Pathway. , 2020, Trends in molecular medicine.

[13]  Vasanthanathan Poongavanam,et al.  Solution conformations explain the chameleonic behaviour of macrocyclic drugs. , 2020, Chemistry.

[14]  Giulia Caron,et al.  Flexibility in early drug discovery: focus on the beyond-Rule-of-5 chemical space. , 2020, Drug discovery today.

[15]  Giulia Caron,et al.  Intramolecular hydrogen bonding: An opportunity for improved design in medicinal chemistry , 2019, Medicinal research reviews.

[16]  M. Shalaeva,et al.  Experimental lipophilicity for beyond Rule of 5 compounds , 2019, Future Drug Discovery.

[17]  B. Stecca,et al.  Impact of ERK5 on the Hallmarks of Cancer , 2019, International journal of molecular sciences.

[18]  Stanislaw Wlodek,et al.  Conformational Sampling of Macrocyclic Drugs in Different Environments: Can We Find the Relevant Conformations? , 2018, ACS omega.

[19]  Michael D Shultz,et al.  Two Decades under the Influence of the Rule of Five and the Changing Properties of Approved Oral Drugs. , 2018, Journal of medicinal chemistry.

[20]  G. Caron,et al.  Log P as a tool in intramolecular hydrogen bond considerations. , 2018, Drug discovery today. Technologies.

[21]  Vasanthanathan Poongavanam,et al.  Impact of Dynamically Exposed Polarity on Permeability and Solubility of Chameleonic Drugs Beyond the Rule of 5. , 2018, Journal of medicinal chemistry.

[22]  M. Wendt,et al.  Beyond the Rule of 5: Lessons Learned from AbbVie's Drugs and Compound Collection. , 2017, Journal of medicinal chemistry.

[23]  Bradley C Doak,et al.  Drug discovery beyond the rule of 5 - Opportunities and challenges , 2017, Expert opinion on drug discovery.

[24]  Marie-Claude Blatter,et al.  Kinetic Models of Cyclosporin A in Polar and Apolar Environments Reveal Multiple Congruent Conformational States , 2016, J. Chem. Inf. Model..

[25]  Bradley C Doak,et al.  Cell permeability beyond the rule of 5. , 2016, Advanced drug delivery reviews.

[26]  S. Vajda,et al.  Quantifying the chameleonic properties of macrocycles and other high-molecular-weight drugs. , 2016, Drug discovery today.

[27]  Bradley C Doak,et al.  How Beyond Rule of 5 Drugs and Clinical Candidates Bind to Their Targets. , 2016, Journal of medicinal chemistry.

[28]  A. Leo,et al.  An NMR method for the quantitative assessment of intramolecular hydrogen bonding; application to physicochemical, environmental, and biochemical properties. , 2014, The Journal of organic chemistry.

[29]  Fabrizio Giordanetto,et al.  Oral druggable space beyond the rule of 5: insights from drugs and clinical candidates. , 2014, Chemistry & biology.

[30]  Suk-Joon Hyung,et al.  Detection of conformation types of cyclosporin retaining intramolecular hydrogen bonds by mass spectrometry , 2014, Analytical and Bioanalytical Chemistry.

[31]  M. Shalaeva,et al.  High throughput method for the indirect detection of intramolecular hydrogen bonding. , 2014, Journal of medicinal chemistry.

[32]  Giulia Caron,et al.  Integrating intramolecular hydrogen bonding (IMHB) considerations in drug discovery using ΔlogP as a tool. , 2013, Journal of medicinal chemistry.

[33]  James J. P. Stewart,et al.  Optimization of parameters for semiempirical methods VI: more modifications to the NDDO approximations and re-optimization of parameters , 2012, Journal of Molecular Modeling.

[34]  Cristiano Ruch Werneck Guimarães,et al.  Use of 3D Properties to Characterize Beyond Rule-of-5 Property Space for Passive Permeation , 2012, J. Chem. Inf. Model..

[35]  Chris Morley,et al.  Open Babel: An open chemical toolbox , 2011, J. Cheminformatics.

[36]  Alexander Alex,et al.  Intramolecular hydrogen bonding to improve membrane permeability and absorption in beyond rule of five chemical space , 2011 .

[37]  D. E. Clark What has polar surface area ever done for drug discovery? , 2011, Future medicinal chemistry.

[38]  W. Sherman,et al.  Prediction of Absolute Solvation Free Energies using Molecular Dynamics Free Energy Perturbation and the OPLS Force Field. , 2010, Journal of chemical theory and computation.

[39]  Woody Sherman,et al.  ConfGen: A Conformational Search Method for Efficient Generation of Bioactive Conformers , 2010, J. Chem. Inf. Model..

[40]  B. Kuhn,et al.  Intramolecular hydrogen bonding in medicinal chemistry. , 2010, Journal of medicinal chemistry.

[41]  Bernard Testa,et al.  Intramolecular Interactions Encoded in Lipophilicity: Their Nature and Significance , 2008 .

[42]  Matthew P Jacobson,et al.  Conformational flexibility, internal hydrogen bonding, and passive membrane permeability: successful in silico prediction of the relative permeabilities of cyclic peptides. , 2006, Journal of the American Chemical Society.

[43]  Conrad C. Huang,et al.  UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..

[44]  P. Selzer,et al.  Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. , 2000, Journal of medicinal chemistry.

[45]  D. E. Clark,et al.  Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 2. Prediction of blood-brain barrier penetration. , 1999, Journal of pharmaceutical sciences.

[46]  Philip M. Dean,et al.  Three-dimensional hydrogen-bond geometry and probability information from a crystal survey , 1996, J. Comput. Aided Mol. Des..

[47]  W. L. Jorgensen,et al.  Development and Testing of the OPLS All-Atom Force Field on Conformational Energetics and Properties of Organic Liquids , 1996 .

[48]  N el Tayar,et al.  Morphine 6-glucuronide and morphine 3-glucuronide as molecular chameleons with unexpected lipophilicity. , 1991, Journal of medicinal chemistry.

[49]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.

[50]  R. Bazzo,et al.  NMR Analysis of Molecular Flexibility in Solution: A New Method for the Study of Complex Distributions of Rapidly Exchanging Conformations. Application to a 13-Residue Peptide with an 8-Residue Loop , 1995 .